A little-known aim of China's Belt and Road Initiative (BRI) is 'people-to-people cultural exchange', including active promotion of Traditional Chinese Medicine (TCM) in BRI countries. On a global scale, this is likely to increase both TCM demand and the sourcing of wildlife-based TCM ingredients from new areas. Any rapid increase in wildlife demand risks exacerbating illegal and unsustainable trade but, with careful management, BRI-TCM could also present opportunities for well-governed supply chains, creating sustainable livelihoods for rural harvesters. With China reaching out to BRI countries to cooperate on the marketing, registration and promotion of TCM products, there is now a critical short-term window for the identification of these risks and opportunities, and to ensure that sustainability is built into these markets from the start.
T he Belt and Road Initiative (BRI) is projected to directly connect China to over 130 countries 1 , creating a network covering approximately 62% of the world's population and 30% of current global gross domestic product 2 . High-profile road, rail and maritime infrastructure projects form a key part of the BRI, and the enhanced connectivity that they will provide is likely to facilitate trade and economic development for China and the countries it is connecting with 3 . However, physically building links between BRI countries and China is only one of the BRI's five main goals, with others focusing on coordinating policy, removing barriers to trade, integrating financial systems and developing closer 'people-topeople ties' 4 . This final goal refers to cultural exchange between China and BRI countries, with specific reference to areas such as education, tourism and development aid, as well as medicine and health. Mentioned specifically is the cultural export of Traditional Chinese Medicine (TCM) 5, 6 , the promotion of which in BRI countries will build on wider efforts by the Chinese government to strengthen the reach and importance of TCM within China 7 . The use of TCM outside of China has been taking place for some time [8] [9] [10] [11] , but the BRI is providing a structure through which to expand TCM markets further and more rapidly using the official TCM Belt and Road Development Plan 5 . This expansion is likely to be supported by the inclusion of TCM in the World Health Organization's 2019 International Classification of Disease, which is used by doctors and medical insurance companies around the world 12 .
Since the BRI was announced in 2013, 43 TCM cooperation centres have been established in 35 countries 4 . In addition, according to self-reported Chinese government figures, there was a 54% increase in TCM sales in BRI countries between 2016 and 2017 (ref. 7 ). This is likely to just be the beginning, as China plans to expand the building of TCM hospitals and cooperation centres to new BRI regions, including Europe and the Middle East 5 .
As TCM demand grows, there will be an opportunity for TCM companies to develop new sources of ingredients derived from the natural plant, animal and fungal resources of BRI countries 6 . This increased TCM supply and demand presents a potentially major but unexplored biodiversity conservation threat 13 , especially as many planned BRI land 'belts' and marine 'roads' pass through important biodiversity hotspots 14 . Further, in several cases the BRI will overlay existing illegal wildlife trade (IWT) routes, along which wildlife is trafficked from regions such as Southeast Asia, Central Asia and East Africa 15 . However, if managed carefully, emerging TCM supply chains and markets may also represent an opportunity for sustainable development if they are shaped by evidence-based strategies and accompanied by nurturing of robust and equitable governance arrangements, as well as social and environmental safeguards. Whilst broad strategies for sustainability of BRI projects have been explored in the scientific literature 16, 17 , the potential effects of the expansion of TCM demand and supply have not yet been recognized, and there have been no explicit commitments from policy-makers on TCM sustainability planning. Nevertheless, broader commitments to sustainability have been made, including a Memorandum of Understanding between China and the United Nations Environment Programme on a 'Green BRI' , and separate agreements with over 30 BRI countries for local ecological protection 4 . With the first phase of the BRI almost complete and plans for the next phases underway, there is a critical, but narrow, window for China to work collaboratively with its BRI partners to consider the wildlife impacts of expanding TCM markets and to turn possible threats into opportunities. This aligns well with realizing China's domestic vision of achieving ecological civilization and balancing people's well-being and environmental protection 18 .
Potential BRI-TCM risks to biodiversity
BRI-TCM promotion will lead to expanding demand for TCM, which has the potential to threaten wild populations of harvested species as previous increases in demand have shown 12 . Existing studies of TCM expansion outside of China, such as in Kenya, have shown that it is likely to involve both a formal sector, represented by well-trained professional practitioners using official products, and an informal sector of opportunistic traders and untrained practitioners 10 .
Whilst examples of farmed ingredients do exist (for example, musk deer (Moschus spp.) 19 ), plants comprise around 80% of TCM products and an estimated 70-90% of these are wild harvested 20 . Wild animal products are also used in some cases, including illegally harvested products from threatened species, as identified by molecular analysis of traded TCM products 21 . The current sustainability of wild harvesting for most TCM ingredients, whether for official formal medicines or for the trade in illegal or unofficial treatments, is unknown. However, illegal and unsustainable harvesting to supply these markets has been reported for orchids (Orchidaceae spp.) and other medicinal plants 22, 23 and animals ranging from rhinos (Rhinocerotidae spp.) to sea cucumbers (Holothuroidea spp.) 24, 25 , both within and outside of China. The BRI is likely to increase connectivity along existing IWT routes, including the routes for species used in TCM such as pangolins (Manidae spp.), which run along the BRI's Maritime Silk Road between Southeast Asia and Southern China 26 , and saigas (Saiga tartarica), which run from Central Asia to Singapore 27 . Few of these risks have been explored in any detail, but the China-Pakistan corridor has been noted as likely to facilitate an increase in the illegal trade of large carnivores to Southeast Asia, including for use in medicinal products 28 .
Although increasing pressure on existing resources can be predicted to some degree, the expansion of harvesting to new areas and even new species presents a novel and unknown threat that is more difficult to plan for. The emergence of a trade in bones from captive lions in South Africa to substitute for tiger bone in health tonics was unexpected 29 . The ensuing strong response against the use of captive lion bones has the potential to backfire and lead to increased illegal hunting of large felids worldwide, including jaguars and wild lions.
Chinese pharmaceutical companies plan to shift some of their sourcing and production closer to new BRI consumer markets, to reduce shipping costs and increase the volume of supply 6 . As Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) regulations only apply to international trade, there will be no CITES oversight of the sustainability and legality of trade where sourcing and supply are within the same country. Although this may streamline supply chains, there is also the risk that harvesting of target species will not be adequately regulated by domestic laws in different BRI countries, especially if trade in that species has not been a threat in the past. This has already been demonstrated in other contexts, such as in the case of sea cucumbers, the demand for which increased too rapidly for effective management responses to be implemented concurrently in many places 24 .
One factor that may reduce the risk of the new and unregulated supply chains that are developing for these species is the importance of geographical origin to TCM practitioners and consumers, linked to the notion of 'daodi' of TCM ingredients. Daodi is a Chinese concept that links place of origin to the quality of the final medicinal product, meaning that an ingredient derived from the same species may be judged to be of higher quality if it is sourced in a certain place in its native range, compared to elsewhere 30 . Whilst several TCM species cultivated in Europe and the United States are still judged to be of good quality by TCM practitioners 31 , the role of daodi should be carefully considered when assessing the probable risks and opportunities for species outside of China. In addition, the risk of increased harvesting for daodi species within China itself should be considered, as consumers in BRI countries may show preferences for these products even when locally sourced alternatives are available.
Existing examples of TCM use outside of China, such as in Tanzania and Malaysia, have illustrated that these markets can be extremely heterogeneous, focusing on different forms of medicine and specific products tailored to local contexts 8, 11 . In Cameroon, TCM and local traditional medicine are sometimes combined, and medicinal plant research has been carried out by joint Cameroonian-Chinese teams 9 . It is therefore possible that in these situations, local species may be incorporated into treatments, either as substitutes for TCM ingredients that are not accessible, perhaps due to CITES, or as novel ingredients. The risks of this occurring are complex and difficult to predict, especially as many TCM treatments have their origins in Chinese medicines that have been developed over thousands of years. Studies of other Asian traditional medicines, such as Tibetan medicine, have shown that practitioners readily adapt treatments to include local plants, both related and unrelated to the original ingredient 32 . For TCM, even when entirely new ingredients may be unlikely to be incorporated easily into official and endorsed treatments, local species that are very similar to well-established ingredients could be used as substitutes more readily in informal or illegal markets. This may be especially likely in cases where demand outstrips legal supply, as has happened with the use of African pangolin scales as a substitute for those from the Asian species 33 . This could mean that specific threats will vary between different BRI countries and species, complicating risk assessments and requiring a careful evaluation of potential biodiversity conservation impacts in different contexts.
Opportunities for greening BRI-TCM
While they raise considerable risks, expanding TCM markets may also represent an opportunity for scaling up sustainable development that could bring real benefits to BRI countries, in particular to rural harvesters. While not possible in every case, many TCM products are based on wild ingredients that could be sourced sustainably or replaced with sustainable alternative products. Countries in the BRI have both diverse environmental conditions and specific local capacities, as well as forms of expertise that would suit different potential sustainability solutions. In some cases, wild harvesting can be carried out sustainably and can offer multiple benefits, including engaging local communities in management and incentivizing conservation of species' habitats. For example, in the case of the high-value TCM trade of caterpillar fungus (Ophiocordyceps sinensis), sustainable wild harvesting has been shown to be challenging to achieve 34 , although there is broad agreement that strong national, sub-national or community-based management is a key step towards sustainability 35, 36 . Use of rigorous standards in TCM supply chains may promote sustainability, such as the internationally recognized FairWild Standard that has already been applied to the harvest of wild plants used in TCM, including southern Schisandra (Schisandra sphenanthera) in China 37 . For this species, the formation of a village cooperative to manage the trade led to increased yields, and engagement with TCM companies from the start ensured that there was a stable market for the product 37 . Despite past successes, careful assessments must take place in order to determine whether wild harvesting is suitable for a species within its governance context 38 . However, for TCM, efforts made so far to assess wild-sourced plant ingredients have concluded that several important species, such as eleuthero (Eleutherococcus senticosus) and Mongolian dandelion (Taraxacum mongolicum), can be harvested sustainably on a commercial scale if appropriate standards are applied 39 . Other examples include saiga horn harvesting, which is also potentially sustainable and could provide income to rural people in Kazakhstan 40 ; sustainable use is a long-term goal of the species' range states 41 .
Where wild harvesting is not viable, farming or other ex-situ production may be an option. For example, wild harvesting of certain species used in TCM may be prohibited by law, whereas farmed products of the same species may be legal to trade. This includes CITES Appendix I species that are traded internationally, as well as some captive-bred species such as lions and bears, which are traded in legal domestic markets in certain countries. There are also TCM species where the sustainability of commercial-scale wild harvesting is unknown or unlikely, including many orchids such as tianma (Gastrodia elata) 22 . Farming to produce TCM ingredients has been taking place for decades in China and takes many forms, from the captive breeding of animals such as musk deer 19 to large-scale cultivation and semi-wild cultivation of Dendrobium orchids 22 . Whilst farming may be able to supply large volumes of TCM ingredients, there are several issues that must be considered before farming is used as a sustainability strategy. For example, farming may shift benefits of trade away from poor rural communities to wealthier people who own land and infrastructure, and in plant examples it has been shown to increase wild harvesting where founder stock is needed to establish a farm 42 . Whilst there is very little clear evidence linking farming with either increases or decreases in illegal harvest of wild populations for most species, it has been proposed as a risk and further research into these links is needed for different species and local contexts. Further, the farming of animals to supply TCM markets is often controversial due to concerns about animal welfare 43 .
Finally, in some cases, neither farming nor wild harvesting may be possible on a commercial scale. This may include threatened species that are currently difficult to breed in captivity or for which farming is unlikely to be feasible, such as pangolins 44 , or those for which farming is banned, as in the case of the bear bile trade, where legal farming exists in China but is being phased out in Laos, Vietnam and South Korea 45 . In such cases where it is not possible to source a product legally and sustainably, there may be opportunities to identify sustainable alternative ingredients. This may include the use of products from domesticated species that may already be recognized within the TCM pharmacopeia (for example, water buffalo horn rather than rhino or saiga horn 46 ), or that could be identified based on analysis of their shared properties with threatened TCM species (for example, similar protein content 47 ). Whatever the source, any potential alternative ingredients should be identified carefully, in collaboration with TCM experts, and with consideration of how likely consumers and practitioners will be to use them.
A strategy for sustainability
With the first BRI phase due to be completed in 2020, there is now a critical, but short-term, window of opportunity to implement strategies to mitigate the potential negative effects on biodiversity, and to turn the potential negative effects into opportunities for sustainable development. However, considering the diversity of different approaches to sustainable TCM supply chains, it is clear that careful planning is needed to ensure that they fit specific species and local contexts. In particular, attention must be paid to the strength of governance, as this may undermine efforts to promote sustainability. We propose a four-step approach to developing robust sustainability strategies for BRI-TCM markets (Fig. 1) .
Step 3 Monitor and enforce
Step 2 Develop sustainability strategies Work with TCM stakeholders and local conservationists to find out which ingredient could threaten biodiversity.
Identify hotspots of risk and opportunity within the BRI.
Step 1 Understand the threats Work with TCM companies to develop responsible sourcing guidelines in supply chains.
Invest in training practitioners to avoid unsustainable products.
Develop standards for emerging BRI markets.
Implement proactive monitoring of TCM markets and supply chains.
Work with key stakeholders in BRI countries to develop effective management of wild resources, including enforcement of regulations and application of sustainability standards.
Step 4 Implement sustainable use
Seek funding to develop sustainable-use projects or support existing community-based sustainable wild harvesting/farming initiatives.
Focus on areas that benefit both conservation and poverty alleviation. Our approach could be applied to specific taxonomic groups across national borders, or focus on all TCM species within a country or region. Whatever the framing, the approach at each step should be based on robust scientific research, as well as collaboration across sectors and disciplines. This will allow the development of evidence-based sustainability strategies that are tailored to realworld situations. It will also allow strategies to be based on current best practice in sustainable wild harvesting, farming or propagation, focusing on the approaches that contribute to local livelihoods and provide important economic benefits.
For instance, Nepal is a key BRI country with potential risks from BRI-TCM due to existing high levels of harvesting of multiple species for TCM trade 23, 48 . However, opportunities for the development of sustainable medicinal trade are great, and similar initiatives have been welcomed by the Nepali authorities 49 , partly due to the significant development benefits they present for harvesters in rural areas, who are disproportionately poor and marginalized compared to the general population 50 . Determining the best ways to develop sustainable BRI-TCM trade in Nepal using our four steps would require data on the current and potential future patterns of TCM supply and demand, as well as the legal frameworks that regulate harvest and trade of different species. This could be obtained through the literature on current TCM trade in Nepal, trade and seizure databases and engagement with key stakeholders, including governments, non-governmental organizations and other experts in Nepal and China, and Community Forest Users Groups in rural areas of Nepal where TCM products are currently harvested. Through an evidence-based and expert elicitation approach, it is possible to sort species and areas into three categories: those that are already threatened by harvest; those that would be at-risk if demand increased; and those that represent the best opportunities for sustainable use. These lists would then be used to prioritize species and areas for further action in Steps 2-4, particularly to develop sustainablesourcing guidelines in collaboration with the TCM private sector and to inform management decisions for specific species in Nepal.
Our proposed approach is highly collaborative and involves crossborder cooperation. As the architect of the BRI, China is in a unique position to lead on such cooperation, further demonstrating its commitment to green BRI development 17 . This is especially important as, after years of receiving criticism from the international community for its environmental issues, China is showing increasing domestic policy commitments to sustainable economic development as part of its ecological civilization plan 16 . Suggestions that the BRI will be used to 'outsource' unsustainable or environmentally damaging practices to other countries have been made 15 , and there are calls for all BRI projects and policies to be regulated in the same way as domestic development 16 . As China prepares to host the 15th Conference of Parties to the Convention on Biological Diversity in Kunming in October 2020, it has the opportunity to use the expansion of TCM markets as a flagship project to demonstrate its commitment to ensuring ecological civilization principles are applied on a global scale, and to position itself as a global leader in sustainable development.
